Search research articles
Contact Us
Filters
Showing results (61-70 of 189) with videos related to
Page
of 19
Sort By:
Plos One
|
May 13, 2014
Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types
Kihyuck Kwak, Rosie Jiang, Joshua W Wang, et al.
Annals of Plastic Surgery
|
April 3, 2014
Osteoinduction of umbilical cord and palate periosteum-derived mesenchymal stem cells on poly(lactic-co-glycolic) acid nanomicrofibers
Montserrat Caballero, Andrew K Pappa, Katherine S Roden, et al.
Presse Medicale (Paris, France : 1983)
|
February 22, 1992
[Treatment of lung cancers by high dose curietherapy]
J P Homasson, S Roden, M Angebault, et al.
Journal of Virology
|
February 29, 2008
Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies
Patricia M Day, Ratish Gambhira, Richard B S Roden, et al.
Frontiers in Bioscience : a Journal and Virtual Library
|
November 28, 2006
Vaccines against human papillomavirus
Yen-Yu Lin, Hannah Alphs, Chien-Fu Hung, et al.
Vaccine
|
June 1, 2019
Incorporation of RG1 epitope into HPV16L1-VLP does not compromise L1-specific immunity
C Schellenbacher, B Huber, M Skoll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2021
Cervical Cancer Immunotherapy: Facts and Hopes
Louise Ferrall, Ken Y Lin, Richard B S Roden, et al.
The Laryngoscope
|
May 2, 2019
Infectivity of murine papillomavirus in the surgical byproducts of treated tail warts
Simon R Best, Daniel Esquivel, Rebecca Mellinger-Pilgrim, et al.
Cancer Research
|
July 5, 2006
CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells
Rongcun Yang, Zhong Cai, Yuan Zhang, et al.
Journal of Virology
|
January 21, 2021
EXPRESSION OF E8^E2 IS REQUIRED FOR WART FORMATION BY MOUSE PAPILLOMAVIRUS 1 IN VIVO
Frank Stubenrauch, Elke Straub, Katrin Klein, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 189) with videos related to
Sort By:
Page
of 19
Plos One
|
May 13, 2014
Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types
Kihyuck Kwak, Rosie Jiang, Joshua W Wang, et al.
Annals of Plastic Surgery
|
April 3, 2014
Osteoinduction of umbilical cord and palate periosteum-derived mesenchymal stem cells on poly(lactic-co-glycolic) acid nanomicrofibers
Montserrat Caballero, Andrew K Pappa, Katherine S Roden, et al.
Presse Medicale (Paris, France : 1983)
|
February 22, 1992
[Treatment of lung cancers by high dose curietherapy]
J P Homasson, S Roden, M Angebault, et al.
Journal of Virology
|
February 29, 2008
Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies
Patricia M Day, Ratish Gambhira, Richard B S Roden, et al.
Frontiers in Bioscience : a Journal and Virtual Library
|
November 28, 2006
Vaccines against human papillomavirus
Yen-Yu Lin, Hannah Alphs, Chien-Fu Hung, et al.
Vaccine
|
June 1, 2019
Incorporation of RG1 epitope into HPV16L1-VLP does not compromise L1-specific immunity
C Schellenbacher, B Huber, M Skoll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2021
Cervical Cancer Immunotherapy: Facts and Hopes
Louise Ferrall, Ken Y Lin, Richard B S Roden, et al.
The Laryngoscope
|
May 2, 2019
Infectivity of murine papillomavirus in the surgical byproducts of treated tail warts
Simon R Best, Daniel Esquivel, Rebecca Mellinger-Pilgrim, et al.
Cancer Research
|
July 5, 2006
CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells
Rongcun Yang, Zhong Cai, Yuan Zhang, et al.
Journal of Virology
|
January 21, 2021
EXPRESSION OF E8^E2 IS REQUIRED FOR WART FORMATION BY MOUSE PAPILLOMAVIRUS 1 IN VIVO
Frank Stubenrauch, Elke Straub, Katrin Klein, et al.
Page
of 19